Proteasomal Dysfunction and Endoplasmic Reticulum Stress Enhance Trafficking of Prion Protein Aggregates through the Secretory Pathway and Increase Accumulation of Pathologic Prion Protein*
- Max Nunziante‡,
- Kerstin Ackermann‡,
- Kim Dietrich‡,
- Hanna Wolf‡,
- Lars Gädtke‡,
- Sabine Gilch‡§,
- Ina Vorberg‡,1,
- Martin Groschup¶ and
- Hermann M. Schätzl‡§,2
- From the ‡Institute of Virology, Prion Research Group, Technische Universität München, 81675 Munich, Germany,
- the §Departments of Veterinary Sciences and Molecular Biology, University of Wyoming, Laramie, Wyoming 82071, and
- the ¶Institute for Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Riems, Germany
- ↵2 To whom correspondence should be addressed: Depts. of Veterinary Sciences and Molecular Biology, University of Wyoming, MICRO/Molecular Biology, UW Shipping, 16th and Gibbons St., Laramie, WY 82071. Tel.: 307-766-6605; E-mail: hschatzl{at}uwyo.edu.
Abstract
A conformational change of the cellular prion protein (PrPc) underlies formation of PrPSc, which is closely associated with pathogenesis and transmission of prion diseases. The precise conformational prerequisites and the cellular environment necessary for this post-translational process remain to be completely elucidated. At steady state, glycosylated PrPc is found primarily at the cell surface, whereas a minor fraction of the population is disposed of by the ER-associated degradation-proteasome pathway. However, chronic ER stress conditions and proteasomal dysfunctions lead to accumulation of aggregation-prone PrP molecules in the cytosol and to neurodegeneration. In this study, we challenged different cell lines by inducing ER stress or inhibiting proteasomal activity and analyzed the subsequent repercussion on PrP metabolism, focusing on PrP in the secretory pathway. Both events led to enhanced detection of PrP aggregates and a significant increase of PrPSc in persistently prion-infected cells, which could be reversed by overexpression of proteins of the cellular quality control. Remarkably, upon proteasomal impairment, an increased fraction of misfolded, fully glycosylated PrP molecules traveled through the secretory pathway and reached the plasma membrane. These findings suggest a novel pathway that possibly provides additional substrate and template necessary for prion formation when protein clearance by the proteasome is impaired.
- ER Quality Control
- ER Stress
- Neurodegenerative Diseases
- Prions
- Proteasome
- Prion Protein
- Quality Control
Footnotes
-
↵* This work was also supported by Deutsche Forschungsgemeinschaft Scha594/7-1, SFB-596 (Project A8), and Alberta Prion Research Institute, Alberta, Canada (Projects 20080238 and 20090122).
-
↵
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3.
- Received June 15, 2011.
- Revision received August 5, 2011.
- © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.











